Dr Ciro J Carafa, MD - Medicare Internal Medicine in Lodi, NJ

Dr Ciro J Carafa, MD is a medicare enrolled "Internal Medicine" physician in Lodi, New Jersey. He went to Js Weill Medical College, Cornell University and graduated in 1977 and has 47 years of diverse experience with area of expertise as Internal Medicine. He is a member of the group practice Hackensack Meridian Health Medical Group - Primary Care Pc and his current practice location is 120 S Main St, Lodi, New Jersey. You can reach out to his office (for appointments etc.) via phone at (973) 473-7870.

Dr Ciro J Carafa is licensed to practice in New Jersey (license number 25MA04037700) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1154485449.

Contact Information

Dr Ciro J Carafa, MD
120 S Main St,
Lodi, NJ 07644-2204
(973) 473-7870
(973) 472-1455



Physician's Profile

Full NameDr Ciro J Carafa
GenderMale
SpecialityInternal Medicine
Experience47 Years
Location120 S Main St, Lodi, New Jersey
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Dr Ciro J Carafa attended and graduated from Js Weill Medical College, Cornell University in 1977
  NPI Data:
  • NPI Number: 1154485449
  • Provider Enumeration Date: 12/20/2006
  • Last Update Date: 07/31/2020
  Medicare PECOS Information:
  • PECOS PAC ID: 1456475912
  • Enrollment ID: I20100907000047

Medical Identifiers

Medical identifiers for Dr Ciro J Carafa such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1154485449NPI-NPPES
1254201MedicaidNJ

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207RR0500XInternal Medicine - Rheumatology MA40377 (New Jersey)Secondary
207R00000XInternal Medicine 25MA04037700 (New Jersey)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Amedisys Home HealthHackensack, NJHome health agency
Hackensack University Medical CenterHackensack, NJHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Hackensack Meridian Health Medical Group - Primary Care Pc7911003330273

News Archive

First treatment guidelines for NMDA-receptor encephalitis

A mysterious, difficult-to-diagnose, and potentially deadly disease that was only recently discovered can be controlled most effectively if treatment is started within the first month that symptoms occur, according to a new report by researchers from the Perelman School of Medicine at the University of Pennsylvania.

Ohio Medicaid readies new nursing home reimbursement; New nursing home database launched

Ohio's nursing home program in Medicaid - the federal-state health care program for the poor - is changing how nursing homes are paid to try to address their quality. In the meantime, ProPublica launches a nursing home inspection database.

Results of Phase 2a clinical trial of DR Cysteamine announced by Raptor Pharmaceutical

Raptor Pharmaceutical Corp., announced positive findings from the completed treatment phase of its open-label Phase 2a clinical trial of delayed-release cysteamine bitartrate ("DR Cysteamine") in adolescent patients with non-alcoholic steatohepatitis ("NASH"), a progressive form of liver disease believed to affect 2% to 5% of the U.S. population.

Brown University develops new implantable and rechargeable wireless brain sensor

A team of neuroengineers based at Brown University has developed a fully implantable and rechargeable wireless brain sensor capable of relaying real-time broadband signals from up to 100 neurons in freely moving subjects.

Campaign for Tobacco-Free Kids issues statement on national tobacco prevention strategy

The national tobacco prevention strategy announced today by Health and Human Services Secretary Kathleen Sebelius provides a timely and much-needed shot in the arm for the nation's efforts to combat tobacco use, the number one cause of preventable death in America. It calls for bold and historic action that will improve health, save lives and save health care costs for employers, workers and taxpayers across the country.

Read more Medical News

› Verified 4 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Ciro J Carafa allows following entities to bill medicare on his behalf.
Entity NameHackensack Meridian Health Medical Group - Specialty Care Pc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1215989249
PECOS PAC ID: 9133032519
Enrollment ID: O20031111000524

News Archive

First treatment guidelines for NMDA-receptor encephalitis

A mysterious, difficult-to-diagnose, and potentially deadly disease that was only recently discovered can be controlled most effectively if treatment is started within the first month that symptoms occur, according to a new report by researchers from the Perelman School of Medicine at the University of Pennsylvania.

Ohio Medicaid readies new nursing home reimbursement; New nursing home database launched

Ohio's nursing home program in Medicaid - the federal-state health care program for the poor - is changing how nursing homes are paid to try to address their quality. In the meantime, ProPublica launches a nursing home inspection database.

Results of Phase 2a clinical trial of DR Cysteamine announced by Raptor Pharmaceutical

Raptor Pharmaceutical Corp., announced positive findings from the completed treatment phase of its open-label Phase 2a clinical trial of delayed-release cysteamine bitartrate ("DR Cysteamine") in adolescent patients with non-alcoholic steatohepatitis ("NASH"), a progressive form of liver disease believed to affect 2% to 5% of the U.S. population.

Brown University develops new implantable and rechargeable wireless brain sensor

A team of neuroengineers based at Brown University has developed a fully implantable and rechargeable wireless brain sensor capable of relaying real-time broadband signals from up to 100 neurons in freely moving subjects.

Campaign for Tobacco-Free Kids issues statement on national tobacco prevention strategy

The national tobacco prevention strategy announced today by Health and Human Services Secretary Kathleen Sebelius provides a timely and much-needed shot in the arm for the nation's efforts to combat tobacco use, the number one cause of preventable death in America. It calls for bold and historic action that will improve health, save lives and save health care costs for employers, workers and taxpayers across the country.

Read more Medical News

› Verified 4 days ago

Entity NameHackensack Meridian Health Medical Group - Primary Care Pc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1336203538
PECOS PAC ID: 7911003330
Enrollment ID: O20070502000000

News Archive

First treatment guidelines for NMDA-receptor encephalitis

A mysterious, difficult-to-diagnose, and potentially deadly disease that was only recently discovered can be controlled most effectively if treatment is started within the first month that symptoms occur, according to a new report by researchers from the Perelman School of Medicine at the University of Pennsylvania.

Ohio Medicaid readies new nursing home reimbursement; New nursing home database launched

Ohio's nursing home program in Medicaid - the federal-state health care program for the poor - is changing how nursing homes are paid to try to address their quality. In the meantime, ProPublica launches a nursing home inspection database.

Results of Phase 2a clinical trial of DR Cysteamine announced by Raptor Pharmaceutical

Raptor Pharmaceutical Corp., announced positive findings from the completed treatment phase of its open-label Phase 2a clinical trial of delayed-release cysteamine bitartrate ("DR Cysteamine") in adolescent patients with non-alcoholic steatohepatitis ("NASH"), a progressive form of liver disease believed to affect 2% to 5% of the U.S. population.

Brown University develops new implantable and rechargeable wireless brain sensor

A team of neuroengineers based at Brown University has developed a fully implantable and rechargeable wireless brain sensor capable of relaying real-time broadband signals from up to 100 neurons in freely moving subjects.

Campaign for Tobacco-Free Kids issues statement on national tobacco prevention strategy

The national tobacco prevention strategy announced today by Health and Human Services Secretary Kathleen Sebelius provides a timely and much-needed shot in the arm for the nation's efforts to combat tobacco use, the number one cause of preventable death in America. It calls for bold and historic action that will improve health, save lives and save health care costs for employers, workers and taxpayers across the country.

Read more Medical News

› Verified 4 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Ciro J Carafa is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Ciro J Carafa, MD
4 Hunter St Ste 206,
Lodi, NJ 07644-1608

Ph: (973) 473-3896
Dr Ciro J Carafa, MD
120 S Main St,
Lodi, NJ 07644-2204

Ph: (973) 473-7870

News Archive

First treatment guidelines for NMDA-receptor encephalitis

A mysterious, difficult-to-diagnose, and potentially deadly disease that was only recently discovered can be controlled most effectively if treatment is started within the first month that symptoms occur, according to a new report by researchers from the Perelman School of Medicine at the University of Pennsylvania.

Ohio Medicaid readies new nursing home reimbursement; New nursing home database launched

Ohio's nursing home program in Medicaid - the federal-state health care program for the poor - is changing how nursing homes are paid to try to address their quality. In the meantime, ProPublica launches a nursing home inspection database.

Results of Phase 2a clinical trial of DR Cysteamine announced by Raptor Pharmaceutical

Raptor Pharmaceutical Corp., announced positive findings from the completed treatment phase of its open-label Phase 2a clinical trial of delayed-release cysteamine bitartrate ("DR Cysteamine") in adolescent patients with non-alcoholic steatohepatitis ("NASH"), a progressive form of liver disease believed to affect 2% to 5% of the U.S. population.

Brown University develops new implantable and rechargeable wireless brain sensor

A team of neuroengineers based at Brown University has developed a fully implantable and rechargeable wireless brain sensor capable of relaying real-time broadband signals from up to 100 neurons in freely moving subjects.

Campaign for Tobacco-Free Kids issues statement on national tobacco prevention strategy

The national tobacco prevention strategy announced today by Health and Human Services Secretary Kathleen Sebelius provides a timely and much-needed shot in the arm for the nation's efforts to combat tobacco use, the number one cause of preventable death in America. It calls for bold and historic action that will improve health, save lives and save health care costs for employers, workers and taxpayers across the country.

Read more News

› Verified 4 days ago


Internal Medicine Doctors in Lodi, NJ

Dr. Nora Z Tossounian, MD
Internal Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 160 Essex St Ste 102, Lodi, NJ 07644
Phone: 551-996-8111    Fax: 551-996-8445
Dr. Michael J. Matarese, M.D.
Internal Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 116 Terrace Ave, Lodi, NJ 07644
Phone: 973-473-3896    
Tovah Tripp, M.D.
Internal Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 160 Essex St Ste 102, Lodi, NJ 07644
Phone: 551-996-8111    Fax: 551-996-8445
Dr. Maria Ann Ramos, MD
Internal Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 147 Main St, Suite 6, Lodi, NJ 07644
Phone: 973-777-2888    Fax: 973-777-1088
Dr. Prem Thamman, MD
Internal Medicine
Medicare: Not Enrolled in Medicare
Practice Location: 361 Garibaldi Ave, Lodi, NJ 07644
Phone: 973-773-3556    Fax: 973-773-2337
Mauro Anthony Mecca, M.D.
Internal Medicine
Medicare: May Accept Medicare Assignments
Practice Location: 1 S Main St, Lodi, NJ 07644
Phone: 973-778-3303    Fax: 973-778-3304

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.